Cell & Gene Therapy Committee

Mission Statement

Biocom California’s Cell & Gene Therapy Committee aims to support members operating in the cell & gene therapy space by keeping abreast of industry and federal agency trends, engaging on issues impacting the community, sharing best practices, and providing opportunities to network.

Impact Areas

Share knowledge on common hurdles and best practices in the industry.

Keep abreast of regulation and policies changes that will impact the Cell & Gene Therapy industry.

Participate in events to bolster community engagement and interest in the Cell & Gene Therapy space.

Committee Chairs

Team member placeholder image

Jens Vogel

Senior Vice President and Global Head of Biotech, Bayer Pharmaceuticals Product Supply
Team member placeholder image

Jeffrey Bluestone

CEO and President, Sonoma Biotherapeutics

Committee Admissions Requirements

The Committee is open to Biocom California industry members who work or have an interest in the Cell & Gene Therapy sector. Service providers will be considered for membership on a case-by-case basis. To ensure a strong committee, participation includes two chairs and committee members. A cadence for meetings and special programming will be decided after the first meeting. Members are strongly encouraged to attend meetings or can forward it to someone in their company who they think would be best for the topic in discussion.